Oncorus
Oncolytic Virus Cancer Immunotherapy
3
Funding Rounds
$140.5m
Money raised
Overview
Oncolytic Virus Cancer Immunotherapy
-
Website:
- Business model: B2B
- Headquarters: Cambridge, Massachusetts
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Do Fa** | - | - | |
| Mi* H. Fi*** | - | - | |
| Lu** Ev*** | - | - | - |
| Te* As | - | - | - |
| Ba Ya*** | - | - | - |
| Ma** Ka* Fe**** | - | - | |
| Sp Na* | - | - | - |
Funding series
Funding Series Analysis
The company Oncorus has raised a total of $57m in funding over 3 rounds.
Key Insights:
- Oncorus Series A round, July 2016: $57m
- Oncorus funding round, August 2019: $79.5m
- Oncorus Series A round December 2016: $4m
Oncorus Series A round, July 2016
$57m
Oncorus funding round, August 2019
$79.5m
Oncorus Series A round December 2016
$4m
Industries
Oncorus is active in the following industries: